Mandana Khalili MD

Hepatology & Liver Transplantation

Professor, Medicine, UCSF School of Medicine

1001 Potrero Avenue, Building 5Suite 3D4San Francisco, CA 94110
Phone+1 628-206-8823
Fax+1 628-206-5199

Dr. Khalili is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khalili's full profile Already have an account?

Education & Training

University of California, San FranciscoPost-Doctoral Fellowship, 1998 - 1999
Ochsner Medical CenterPost-Doctoral Fellowship, 1997 - 1998
McGill University Fellowship, 1995 - 1997
University of Ottawa Faculty of MedicineClass of 1992

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1998 - 2027
American Board of Internal Medicine Gastroenterology

Clinical Trials

Natural History of Hepatitis C in Patients With Normal Liver Tests
COMPLETED
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
TERMINATED
PHASE3
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
COMPLETED
PHASE3

Publications & Presentations

PubMed

A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.
Derek D Satre, Leila Taj, Robert J Wong, Hannah R Snyder, Ramsey Cheung
Hepatology. 2026-06-24
Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus Infection.
Myriam Drysdale, Rose Chang, Shuang Wang, Anna Coutinho, Vera Gielen
Journal of Viral Hepatitis. 2026-06-01
Evaluating acute and post-acute COVID-19 symptoms among patients with and without alcohol-related cirrhosis: implications for quality management.
Dhweeja Dasarathy, Jeremy W Luk, Amy M Shui, Robert J Wong, Ramsey Cheung
Alcohol and Alcoholism. 2026-05-13

Journal Articles

Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-Infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study
Mandana Khalili, Mark Sulkowski, Marc G Ghany, Richard K Sterling, Raymond T Chung, David E Kleiner, Mamta K Jain, Nature

Press Mentions

How We Could Test for Unhealthy Alcohol Use Before It's Too LateDecember 12th, 2024
Racial Disparities Not Found in Chronic Hepatitis B Treatment InitiationApril 11th, 2023
UCSF to Coordinate Health Disparities Research in Multiple Chronic Diseases with $22.5M GrantOctober 18th, 2021

Grant Support

NRSA Hepatology Training GrantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2001–2027
NRSA Hepatology Training GrantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2001–2027
Liver Cirrhosis Network: Longitudinal and Clinical Trial StudiesUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2026
Liver Cirrhosis Network: Longitudinal and Clinical Trial StudiesUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2026
Liver Cirrhosis Network: Longitudinal and Clinical Trial StudiesUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2026